VIE Equity Snapshot

UCB Weekly Equity Report

UCB SA

Interactive chart JSON snapshot
Latest Close 274.2 EUR 12 Jun 2026
1W Return 4.3% latest completed week
4W Return 14.4% short-term follow-through
12W Return 11.7% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson's disease and restless legs syndrome. It also provides Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. In addition, the company offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx to treat plaque …

Snapshot

What the weekly tape is saying

UCB closed the latest completed week at 274.2 EUR. The 4-week return is 14.4% and the 12-week return is 11.7%. Trend Signal is active, Market Dynamics is -0.43. Setup signature: Balanced read with a 51/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 9.3%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 43 Persistence of active Trend Signal over the last year and current streak.
Momentum 94 Blend of 4-week and 12-week follow-through.
Dynamics 48 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 51 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 73 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
250.8 EUR
Vs Trend Line
9.3%
Fair Value
161.8 EUR
Vs Fair Value
69.5%
52W High
286.8 EUR
52W Low
153.3 EUR
Drawdown
-4.4%
Range Position
90.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 4.3%
4W 14.4%
12W 11.7%
26W 16.1%
52W 68.7%

Trend read

Active Streak
1 weeks
52W Active Weeks
37
52W Active Breadth
71.2%
Sector Scope
AT Healthcare
Sector Rank
10 of 112
Sector Percentile
91.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.43
4W MD Change
67.5%
Relative Strength
-1.70
4W RS Change
76.7%
Expectation
Positive
Probability
60.04%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
39
52W Average
35
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.2%
52W Volatility
5.5%
Upside Weeks
32
Downside Weeks
19
Downside Breadth
36.5%
Avg Gain / Loss
4.2% / -3.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
48.8B

Opportunity signals

  • Trend Signal is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 274.2 EUR 4.3% 250.8 EUR 161.8 EUR -0.43 -1.70 0 On
5 Jun 2026 262.8 EUR 5.0% 249.0 EUR 160.5 EUR -0.83 -2.81 80 Off
29 May 2026 250.3 EUR 3.5% 247.8 EUR 159.4 EUR -1.16 -8.15 75 Off
22 May 2026 241.8 EUR 0.9% 246.7 EUR 158.3 EUR -1.30 -8.60 40 Off
15 May 2026 239.6 EUR 2.3% 246.8 EUR 157.3 EUR -1.33 -7.31 0 Off
8 May 2026 234.2 EUR 2.5% 247.0 EUR 156.3 EUR -1.18 -9.52 80 Off
1 May 2026 228.4 EUR -5.3% 247.7 EUR 155.3 EUR -0.87 -10.24 0 Off
24 Apr 2026 241.2 EUR -7.8% 248.5 EUR 154.4 EUR -0.60 -4.64 0 On
17 Apr 2026 261.5 EUR -4.5% 247.0 EUR 153.4 EUR -0.45 0.12 0 On
10 Apr 2026 273.9 EUR 6.0% 245.1 EUR 152.3 EUR -0.55 7.90 0 On
3 Apr 2026 258.4 EUR 3.5% 242.9 EUR 151.0 EUR -0.70 9.01 166 On
27 Mar 2026 249.6 EUR 1.7% 241.1 EUR 149.9 EUR -0.75 9.40 60 On
20 Mar 2026 245.4 EUR -3.4% 239.4 EUR 148.7 EUR -0.52 9.55 0 On
13 Mar 2026 254.0 EUR 2.2% 237.9 EUR 147.6 EUR 0.03 12.19 68 On